Skip to main content
Ajooni Biotech Limited logo

Ajooni Biotech Limited — Investor Relations & Filings

Ticker · AJOONI ISIN · INE820Y01021 LEI · 335800OAKJWKHF49O339 National Stock Exchange of India Manufacturing
Open in API
Filings indexed 562 across all filing types
Latest filing 2019-11-18 Interim / Quarterly Rep…
Country IN India
Listing National Stock Exchange of India AJOONI

About Ajooni Biotech Limited

https://www.ajoonibiotech.com

Ajooni Biotech Limited specializes in the production and distribution of animal healthcare solutions and nutritional supplements. The company focuses on the livestock sector, offering a comprehensive range of products including compounded cattle feed, mineral mixtures, and specialized supplements formulated to enhance milk productivity and overall animal health. Its portfolio features calcium supplements, liver tonics, and digestive aids designed to meet the specific nutritional needs of dairy animals. The company utilizes research-driven formulations and quality-controlled manufacturing processes to provide effective solutions for livestock management. By prioritizing animal welfare and productivity, it supports the operational efficiency of dairy farming through scientifically developed nutritional interventions.

Recent filings

Filing Released Lang Actions
Reply to Clarification- Financial results
Interim / Quarterly Report Classification · 95% confidence The document is a financial report from Ajooni Biotech Limited dated November 14, 2019, containing unaudited standalone financial results for the half year ended September 30, 2019. It includes detailed financial statements such as the statement of profit and loss, statement of assets and liabilities, and notes. The report references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and Indian Accounting Standard 34 for interim financial reporting. The presence of half-year financial data, review by auditors (limited review report), and board approval indicates this is an Interim / Quarterly Report rather than a full Annual Report or just an announcement. The document length (15,000 characters) and detailed financial data confirm it is a substantive financial report, not merely an announcement or certification. Therefore, the appropriate classification is Interim / Quarterly Report (IR). H1 2020
2019-11-18 English
Outcome of Board Meeting
Interim / Quarterly Report Classification · 95% confidence The document contains an Independent Auditor's Limited Review Report on the Half Yearly and Year to Date Unaudited Standalone Financial Results of Ajooni Biotech Limited for the half year ended September 30, 2019. It references Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and Indian Accounting Standard 34 (Interim Financial Reporting). The document includes detailed financial data for the half year period, including revenue, expenses, profit/loss, and earnings per share. The presence of an auditor's review report and detailed interim financial statements indicates this is an Interim / Quarterly Report rather than a full Annual Report or just an announcement. The document length (15,000 characters) and content confirm it is a substantive financial report, not merely an announcement or certification. Therefore, the correct classification is Interim / Quarterly Report (IR). H1 2020
2019-11-13 English
Board Meeting — Financial Results
Regulatory Filings Classification · 90% confidence The document text is extremely short (63 characters) and contains no substantive content, only a placeholder for an omitted picture. There is no financial data, report title, regulatory references, or any other information to classify it as a specific report type. Given the lack of content, the document cannot be classified as a report or announcement. According to the rules, such minimal content defaults to Regulatory Filings (RNS) as a fallback category.
2019-11-05 English
Reply to Clarification Sought
Regulatory Filings Classification · 90% confidence The document text is extremely short (63 characters) and contains no substantive content, only a placeholder for an omitted picture. There is no financial data, report title, regulatory references, or any other information to classify it as a specific report type. Given the lack of content, the document cannot be classified as a report or announcement. According to the rules, such minimal content defaults to Regulatory Filings (RNS) as a fallback category.
2019-10-23 English
Resignation
Board/Management Information Classification · 95% confidence The document is a letter addressed to the National Stock Exchange of India, dated 14th October 2019, reporting the outcome of a Board meeting held on the same day. It mentions the approval of the resignation of a company secretary and compliance officer. The content is an announcement of a board/management change rather than a full report or financial statement. The document length is short (913 characters), and it is clearly an announcement of a board decision, fitting the category of Board/Management Information (MANG).
2019-10-14 English
Outcome of Board Meeting
Board/Management Information Classification · 95% confidence The document is a letter addressed to the National Stock Exchange of India, reporting the outcome of a board meeting held on 14th October 2019. It specifically mentions the approval of the resignation of a company secretary and compliance officer. The content is about a board/management change announcement. The document is short (913 characters) and focuses on management information rather than financial data or other report types. Therefore, it fits the category of Board/Management Information (MANG).
2019-10-14 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.